125 related articles for article (PubMed ID: 35641296)
1. The First Prognostic Tool to Estimate the Risk of Late Grade ≥3 Xerostomia in Patients Irradiated for Head-and-Neck Cancer.
Rades D; Warwas B; Cremers F; Gerull K; Pries R; Leichtle A; Bruchhage KL; Hakim SG; Schild SE
Anticancer Res; 2022 Jun; 42(6):3035-3039. PubMed ID: 35641296
[TBL] [Abstract][Full Text] [Related]
2. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
3. Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer.
Rades D; Warwas B; Cremers F; Gerull K; Idel C; Bruchhage KL; Hakim SG; Schild SE
Anticancer Res; 2022 Jul; 42(7):3551-3556. PubMed ID: 35790294
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers.
Rades D; Warwas B; Gerull K; Pries R; Leichtle A; Bruchhage KL; Hakim SG; Schild SE; Cremers F
In Vivo; 2022; 36(4):1795-1800. PubMed ID: 35738613
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers.
Warwas B; Cremers F; Gerull K; Leichtle A; Bruchhage KL; Hakim SG; Schild SE; Rades D
Anticancer Res; 2022 May; 42(5):2657-2663. PubMed ID: 35489760
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
[TBL] [Abstract][Full Text] [Related]
7. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
[No Abstract] [Full Text] [Related]
8. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
[TBL] [Abstract][Full Text] [Related]
9. Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity.
Barbosa da Silva JL; Doty RL; Miyazaki JVMK; Borges R; Pinna FR; Voegels RL; Fornazieri MA
Oral Oncol; 2019 Aug; 95():115-119. PubMed ID: 31345378
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
11. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
12. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
[TBL] [Abstract][Full Text] [Related]
13. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
14. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia.
van Dijk LV; Thor M; Steenbakkers RJHM; Apte A; Zhai TT; Borra R; Noordzij W; Estilo C; Lee N; Langendijk JA; Deasy JO; Sijtsema NM
Radiother Oncol; 2018 Sep; 128(3):459-466. PubMed ID: 29958772
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer.
Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT
World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515
[TBL] [Abstract][Full Text] [Related]
16. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy.
Pacholke HD; Amdur RJ; Morris CG; Li JG; Dempsey JF; Hinerman RW; Mendenhall WM
Am J Clin Oncol; 2005 Aug; 28(4):351-8. PubMed ID: 16062076
[TBL] [Abstract][Full Text] [Related]
17. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
[TBL] [Abstract][Full Text] [Related]
18. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
[TBL] [Abstract][Full Text] [Related]
19. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study.
Lin A; Kim HM; Terrell JE; Dawson LA; Ship JA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):61-70. PubMed ID: 12909216
[TBL] [Abstract][Full Text] [Related]
20. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
